Contact & Services Reporting Q2 2026 Evonik has published its preliminary results on June 26, 2026. On August 4, Evonik will publish its final Q2 2026 report. You can access further information here. Why invest in Evonik? Interested in Evonik? Discover the strategic pillars behind our mid-term targets — and why they make Evonik a compelling investment. Publications Roadshow presentationFactbookCMD & other eventsIR NewsRegulated information Investor Relations News July 08, 2026 Investor Relations Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest US$100 million to modernize key equipment – including 100 m³ reactors and other critical systems – enhancing reliability, enabling greater automation, and improving ergonomics and efficiency. June 26, 2026 Investor Relations Second quarter ahead of plan – Evonik raises outlook for 2026 considerably Evonik records a strong business performance in the second quarter. Consequently, the company is raising its forecast for the financial year 2026 considerably. June 18, 2026 Investor Relations Evonik extends efficiency program “Tailor Made” Evonik will implement further structural and cost-cutting measures in the coming years to drive forward the company’s transformation. June 10, 2026 Investor Relations More cost-efficient green hydrogen: Evonik launches pilot plant for high-performance membrane Evonik has begun production of a high-performance membrane at a new pilot plant in Marl, North Rhine-Westphalia. June 10, 2026 Investor Relations Evonik strengthens innovation for profitable growth and greater resilience Evonik is realigning its innovation activities to sharpen its focus on market-driven development and faster execution. May 08, 2026 Investor Relations Evonik defies adverse circumstances in the first quarter Evonik achieved its operating profit target in the first three months of 2026 despite a very difficult business and economic environment. At €475 million, adjusted EBITDA slightly exceeded the company's earnings forecast of around €450 million. View more Events Quarterly Report Q2 2026 Online - On-demand Online 08/04/2026 Quarterly Report Q3 2026 Online - On-demand Online 11/03/2026 Quarterly Report Q4 2026 Online - On-demand Online 03/04/2027 Quarterly Report Q1 2027 Online - On-demand Online 05/04/2027 Quarterly Report Q2 2027 Online - On-demand Online 08/04/2027 Quarterly Report Q3 2027 Online - On-demand Online 11/04/2027
